143 related articles for article (PubMed ID: 34223992)
1. Promotion of rs3746804 (p. L267P) polymorphism to intracellular SLC52A3a trafficking and riboflavin transportation in esophageal cancer cells.
Long L; Pang XX; Zeng FM; Zhan XH; Xie YH; Pan F; Wang W; Liao LD; Xu XE; Li B; Wang LD; Chang ZJ; Li EM; Xu LY
Amino Acids; 2021 Aug; 53(8):1197-1209. PubMed ID: 34223992
[TBL] [Abstract][Full Text] [Related]
2. SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.
Long L; Pang XX; Lei F; Zhang JS; Wang W; Liao LD; Xu XE; He JZ; Wu JY; Wu ZY; Wang LD; Lin DC; Li EM; Xu LY
Cell Mol Life Sci; 2018 Jul; 75(14):2643-2661. PubMed ID: 29428966
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between C20orf54 gene rs3746804 position single nucleotide polymorphism and susceptibility to esophageal squamous cell carcinoma].
Ji AF; Wei W; Yang JZ; Wang JS; Zhao L; Wei ZB; Lian CH; Ma L; Ma L; Wang HL; Qin XQ; Wang LD
Zhonghua Nei Ke Za Zhi; 2012 Dec; 51(12):982-6. PubMed ID: 23327963
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
5. Association of the plasma riboflavin levels and riboflavin transporter (C20orf54) gene statuses in Kazak esophageal squamous cell carcinoma patients.
Ainiwaer J; Tuerhong A; Hasim A; Chengsong D; Liwei Z; Sheyhidin I
Mol Biol Rep; 2013 May; 40(5):3769-75. PubMed ID: 23275236
[TBL] [Abstract][Full Text] [Related]
6. The functional SNP rs3746804 in C20orf54 modifies susceptibility to esophageal squamous cell carcinoma.
Ji A; Ma L; Yang J; Xu Y; Wang J; Lian C; Wang Y; Li D; Dong WL; Wu W
Oncol Res Treat; 2014; 37(11):654-7. PubMed ID: 25427582
[TBL] [Abstract][Full Text] [Related]
7. Plasma Riboflavin Level is Associated with Risk, Relapse, and Survival of Esophageal Squamous Cell Carcinoma.
Li SS; Xu YW; Wu JY; Tan HZ; Wu ZY; Xue YJ; Zhang JJ; Li EM; Xu LY
Nutr Cancer; 2017 Jan; 69(1):21-28. PubMed ID: 27898225
[TBL] [Abstract][Full Text] [Related]
8. Functional SNPs in human C20orf54 gene influence susceptibility to esophageal squamous cell carcinoma.
Ji A; Wang J; Yang J; Wei Z; Lian C; Ma L; Ma L; Chen J; Qin X; Wang Ld; Wei W
Asian Pac J Cancer Prev; 2011; 12(12):3207-12. PubMed ID: 22471455
[TBL] [Abstract][Full Text] [Related]
9. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.
Jiang XR; Yu XY; Fan JH; Guo L; Zhu C; Jiang W; Lu SH
Cancer Lett; 2014 Oct; 353(1):78-86. PubMed ID: 25045844
[TBL] [Abstract][Full Text] [Related]
10. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
Zhang J; Liu S; Zhang D; Ma Z; Sun L
J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
[TBL] [Abstract][Full Text] [Related]
11. Functional single nucleotide polymorphism in C20orf54 modifies susceptibility to esophageal squamous cell carcinoma.
Wei W; Ji A; Wang J; Wei Z; Lian C; Yang J; Ma L; Ma L; Qin X; Wang LD
Dis Esophagus; 2013 Jan; 26(1):97-103. PubMed ID: 22533825
[TBL] [Abstract][Full Text] [Related]
12. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression].
Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136
[No Abstract] [Full Text] [Related]
13. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
[TBL] [Abstract][Full Text] [Related]
14. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
[TBL] [Abstract][Full Text] [Related]
16. HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma.
Wu Y; Yang Y; Xian YS
Chem Biol Interact; 2019 Aug; 308():357-363. PubMed ID: 31152734
[TBL] [Abstract][Full Text] [Related]
17. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
[TBL] [Abstract][Full Text] [Related]
19. [Expression of microRNA-17-5p in esophageal squamous cell carcinoma and its effects on cell proliferation and invasion].
Xu H; Meng XR; Zhou Y; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):105-113. PubMed ID: 32135643
[No Abstract] [Full Text] [Related]
20. CDK11
Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
